Physician profile
Seth P Lerner
NPI 1174548838
$1,295.45
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $827 · 2020: $294 · 2021: $154 · 2024: $20.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $20.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $20.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $242.96 | 2019-2021 | |
| Pfizer INC. | $213.00 | 2019-2020 | |
| Dermira, INC. | $193.11 | 2019-2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $131.74 | 2019-2020 | |
| Almirall LLC | $82.95 | 2019-2020 | |
| Aclaris Therapeutics, INC. | $59.42 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $58.45 | 2021 | |
| Allergan, INC. | $51.60 | 2019-2020 | |
| Sandoz INC. | $47.88 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $42.98 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $41.52 | 2019 | |
| Vyne Pharmaceuticals INC. | $24.74 | 2020 | |
| Janssen Biotech, INC. | $20.24 | 2024 | Erleada |
| Novartis Pharmaceuticals Corporation | $16.85 | 2020 | |
| Amgen INC. | $15.71 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $15.04 | 2020 | |
| Mission Pharmacal Company | $14.47 | 2020 | |
| Journey Medical Corporation | $11.59 | 2020 | |
| Merck Sharp & Dohme LLC | $11.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Lerner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.